Hastings Center Report
Bright-Line Policy and the Future of the Fourteen-Day Rule
Abstract: As global science leaders revisit the fourteen-day rule for human embryo research, this commentary explores why its clarity, stability, and the public trust it has fostered have made it a notable success in science policy—and why any change must be approached with care.
